Skip to content

Original explainers & special topics from Nakitte

Nakitte Featured

Plain-English explainers and deep-dives on the topics behind the headlines — written by Nakitte, for investors who want the context, not just the ticker.

Macro — ASML, Chinese EVs, and the Battery Trap: Is Europe’s Green Dream Turning into a Deindustrialization Nightmare?
🌐 MacroJune 11, 2026

ASML, Chinese EVs, and the Battery Trap: Is Europe’s Green Dream Turning into a Deindustrialization Nightmare?

Europe’s automotive heartland is under siege. In 2025, the continent’s vehicle production remained 15-20% below pre-pandemic levels, with capacity utilization hovering around 55% at many plants. Tens of thousands of jobs have already vanished—90,000 in the auto sector in 2024 alone—with forecasts of hundreds of thousands more at risk in manufacturing and supply chains.

Nakitte Featured10 min
Explainer — Energiewende at the Crossroads: Germany's Energy Transition Amid Geopolitical Shocks and Shifting Global Energy Politics
📘 ExplainerJune 9, 2026

Energiewende at the Crossroads: Germany's Energy Transition Amid Geopolitical Shocks and Shifting Global Energy Politics

Germany’s Energiewende (energy transition) stands as one of the most ambitious national decarbonization efforts in history. Launched with deep roots in the environmental movements of the 1970s and accelerated through landmark legislation in the 2000s and 2010s, it has delivered remarkable growth in renewable electricity while driving substantial greenhouse gas reductions.

Nakitte Featured8 min
Explainer — AI Drug Discovery: Early Clinical Wins Signal a Credible Path to Counter Pharma’s Productivity Crisis and Ease Long-Term Healthcare Cost Pressures
📘 ExplainerJune 8, 2026

AI Drug Discovery: Early Clinical Wins Signal a Credible Path to Counter Pharma’s Productivity Crisis and Ease Long-Term Healthcare Cost Pressures

When Insilico Medicine announced in November 2024 that its generative AI-designed TNIK inhibitor, Rentosertib (formerly ISM001-055), produced dose-dependent improvements in forced vital capacity for idiopathic pulmonary fibrosis patients in a Phase IIa trial—with a +98.4 mL mean gain at the highest dose versus a -62.3 mL decline on placebo—the result carried weight far beyond one disease area.

Nakitte Featured9 min
Explainer — Safe Havens Under Pressure: Geopolitical Tensions and the Reallocation of Capital in Middle East Real Estate
📘 ExplainerJune 5, 2026

Safe Havens Under Pressure: Geopolitical Tensions and the Reallocation of Capital in Middle East Real Estate

The first quarter of 2026 delivered a stark illustration of how geopolitical shocks interact with structural demand in Middle East real estate. As tensions escalated into direct conflict involving Iran, Israel, and the United States, short-term sentiment indicators flashed warning signs — including sharp but temporary drops in certain Dubai real estate indices in March.

Nakitte Featured8 min